中国组织工程研究与临床康复第12卷第53期2008–12–30出版JournalofClinicalRehabilitativeTissueEngineeringResearchDecember30,2008Vol.12,No.53ISSN1673-8225CN21-1539/RCODEN:ZLKHAH10567DepartmentofThoracicSurgery,China-JapanFriendshipHospital,Beijing100029,ChinaLiuDe-ruo☆,Doctor,Chiefphysician,DepartmentofThoracicSurgery,China-JapanFriendshipHospital,Beijing100029,Chinaderuoliu@yahoo.comReceived:2008-02-04Accepted:2008-03-06(54200802040009/G)LiuDR,GuoYQ,ZhaoFR,LiFT,GeBS,ShiB,TianYC,SongZY,ShouYN,ZhangHT,LiangCY,WangZY,ChenJY,BaoT,ZhangZR,XinYL.Allogeneicsinglelungtransplantationin7cases.ZhongguoZuzhiGongchengYanjiuyuLinchuangKangfu2008;12(53):10567-10570(China)[http://www.crter.cnhttp://en.zglckf.com]Allogeneicsinglelungtransplantationin7cases☆LiuDe-ruo,GuoYong-qing,ZhaoFeng-rui,LiFu-tian,GeBing-sheng,ShiBin,TianYan-chu,SongZhi-yi,ShouYan-ning,ZhangHai-tao,LiangChao-yang,WangZai-yong,ChenJing-yu,BaoTong,ZhangZhen-rong,XinYu-lingAbstract:Thepresentcasereportwasdesignedtosummarizetheclinicalexperienceofoperativetechnique,lungpreservation,lungperfusion,andperioperativemanagement.Of7caseswhounderwentallogenicsinglelungtransplantation(LT),3wereidiopathicpulmonaryfibrosis,2werechronicobstructivepulmonarydisease,1wassilicosis,emphysema,andbulla,and1wastuberculosisinbothsidesandpresentedwithdestroyedlunginoneside.Alldonorswerealreadybraindeath.DonorlungswerewellpreservedutilizingEuro-Colinsliquidorlow-potassiumdextransolution.Donorsandrecipientswerematchedinbloodtype.Of7casesselected,5receivedsinglerightlungtransplantation,and2receivedsingleleftLT.End-to-endanastomosiswasperformedforpulmonarybranchesandpulmonaryarteries,whileatrium-to-atriumanastomosiswasperformedforpulmonaryvein.AntibioticsandimmunosuppressantswereroutinelyusedpriortoandsubsequenttoLT.FollowingLT,heartandlungfunction,usageofantibiotics,andadjustmentofimmunosuppressantweremonitored.Stomalcomplicationsregardingbronchusandpulmonaryarteryandveindidnotappearinanypatient.Fivecasessurvivedforabout2months,oneforapproximately1year,andonefornearly2years.Fourcasesdiedofmulti-organfailurecausedbypulmonaryinfection,andoneofseverepulmonaryhemorrhagecausedbyaspergillussydowiinfection.Rejectionoccurredin6cases.Onecasesufferedfromrejectionthreetimes.Selectionofindication,selectionandpreservationofdonorlung,LToperationandpre-andpost-operativemanagementofLThaveacquiredsatisfactoryachievements.Highmortalityoccurredinpatientswithpreoperativepoorcardiacandpulmonaryfunctionsandpostoperativesevereinfectionsaccompanywithapplicationofimmunosuppressant.Keywords:Lungtransplantation;lungpreservation;complication;organgraftINTRODUCTIONSince1987,whenCoopper[1]reportedtheirfirstsuccessfullungtransplantation(LT),approximately20000LTshavebeenperformedallovertheworld.Accordingtointernationalliterature,one-yearmortalityislessthan10%,and5-yearmortalityisnearly50℅.InChina,theLTstartsin1990s[2].Here,wereport7single-LTs,3ofwhichwascooperatedwithotherhospitalsin1990s[3],andtheother4byourselvesbetweenDecember2004andOctober2007.SUBJECTSANDMETHODSDesign:Retrospectivecaseanalysis.Timeandsetting:PerformedatDepartmentsofThoracicSurgery,TangshanWorkers’Hospital,DapingHospital,ThirdMilitaryMedicalUniversityofChinesePLA,theGeneralHospitalofLanzhouMilitaryAreaCommandofChinesePLA,China-JapanFriendshipHospitalin1990sandattheDepartmentofThoracicSurgery,China-JapanFriendshipHospitalbetweenDecember2004andOctober2007.Subjects:Sevenpatientscomprising6malesand1female,averaging51yearsofage(range48-59years)wereenrolledinthisstudy.Allrecipientsreceivedallogenicsinglelungtransplantation.Pathologicaldiagnosisresultsshowedthatofthe7patients,idiopathicpulmonaryfibrosiswasfoundin3patients,chronicobstructivepulmonarydisease(COPD)wasfoundin2patients,tuberculosisinbothsides,anddestroyedlunginonesidewasfoundinpatient,andsilicosis,emphysema,andbullawasfoundin1patient.Inthisstudy,5patientsunderwentsinglerightlungtransplantation,whiletheother2patientsunderwentsingleleftlungtransplantation.Biocularintubationandhighfrequencyventilationwereusedin4cases,andonlybinocularintubationwasusedintherest3cases.Femoralartery-femoralveinbypasswasemployedin3cases.Alldonorswerealreadybraindeath.DonorlungswerewellpreservedutilizingEuro-Colinsliquidorlow-potassiumdextransolution.Thepulmonaryfunctionsofthe7recipientsarepresentedinTable1.ClinicalMedicinePatientFVC(L)FEV1(L)FEV1(%)DonorOperation1234567Average35.211.037.846.431.541.31.1533.40.210.140.380.260.390.520.470.3960.0100.151.9124.1118.190.812.579.6HHHHHHH-RLTLLTRLTRLTRLTRLTLLT-PatientGenderAge(yr)EtiologicalfactorMVV(L/s)1234567AverageFMMMMMM-5348565254593351COPDCOPDDL,RLCCOPDIPFIPFSilicosis-25.411.070.424.839.469.716.436.7Table1Generaldataandlungfunctionofthe7recipientsF:female;M:male;COPD:chronicobstructivepulmonarydisease;DL:destroyedlung;IPF:idiopathicpulmonaryfibrosis;H:health;RLT:rightlungtransplantation.LLT:leftlungtransplantation;MVV:maximalvolun-taryventilation;FVC:forcedvitalcapacity;FEV1:forcedexpiratoryvolumeinonesecondLiuDR,etal,Allogeneicsinglelungtransplantationin7casesP.O.Box1200,Shenyang110004cn.zglckf.com10568www.CRTER.orgTheotherbasicdataofthe7recipientsPatient1exhibitedcontinuousoxygenation,littleactivity,bothlungsinfectedfrequently,rightventricleenlarged,tricuspidvalveregurgitation,andpulmonaryarterypressure(PAP)=66mmHg.Patient2exhibitedoxygenation>10hoursperday,indooractivity,lunginfected,rightventriclemoderatelyenlarged,tricuspidvalvemoderateregurgitation,alittlehighPAP.Patient3exhibitedoxygenation5-10hoursperday,indooractivity,lunginfected,rightventricleenlarged,andtricuspidvalvemildregurgitation.Patient4exhibitedindooractivity,lunginfectedslightly,tricuspidvalvemildregurgitation,andPAP=50mmHg.Patient5exhibitedintermittentoxygenation,indooractivity,cyanosis,lunginfected,leftventricleenlarged,pericardialeffusion,tricuspidvalveseverelyinsufficiency,andPAP=75mmHg.Patient6exhibitedseldomoxygenation,indooractivity,rightventricleenlarged,tricuspidvalvemoderateregurgitation,alittlepericardialeffusion,andPAP=75mmHg.Patient7exhibitedintermittentoxygenation,actindoor,andtricuspidvalvemoderateregurgitation.ThebasicinformationofdonorsAll7donorsweremaleandcompletelybraindeath,with22-48yearsofage.Donorsandrecipientswerematchedinbloodtype.MethodsUsageandmonitorofimmunosuppressantCyclosporinA,azathiopurine,andglucocorticosteroidwereusedinthefirst3patients.Forthe3rdto6thcases,cellcept(500mg,oral)andTacantibody(50mg,i.v.)wereusedonthemorningoftheoperationdayandthedaybeforetransplantation.Forthe7thLT,cellcept(1000mg,oral)andTacantibody(20mg,i.v.)wereusedonthemorningoftheoperationday.500mgmethylprednisolonewasi.v.injectedbeforethepulmonarycirculationwasreopenedduringtheoperation.Postoperatively,FK506,Cellcept,andcorticosteroidwereusedincombination.ThedosageofFK506wasfollowedbyitsconcentrationinthecirculationandreducedgradually:theconcentrationofFK506shouldbe15-20μg/L(4degree)forthefirstpostoperative21days,then10-15μg/L(3degree)forthefollowing5weeks,8-10μg/L(2degree)for1monthsequentially,andfinally4-7μg/L(1degree)forlifelong.ApplicationofantibioticsThe3rdgenerationofcephalosporinwasgivenjust30minutesbefore(2g)andsubsequenttooperation.Iflungbacterialinfectionoccurredpreoperatively,suchaspatients1,4and6,cephalosporinwasalsogiventocontroltheinfectionandthenproperantibioticswasselectedaccordingtobacterialcultureanddrugsensitivity.Aciclovirwasroutinelyusedforanti-virus.Ifthetransplantedlungwasinfectedbyviruspostoperatively,2-weekintravenousandsubsequent12-weekoraladministrationofaciclovirwasgiven.Aciclovirshouldbeintravenouslyadministeredfor3monthsinseverecases.Fluconazolwasroutinelyusedforanti-fungus.MonitoringPostoperatively,all7recipientsweresenttoICU,andmechanicalventilationwasperformed.Parametersmonitoredincludedelectrocardiogram,pulseoxygensaturation,partialpressureofcarbondioxideinartery,centralvenouspressure,pulmonaryarterypressure,pulmonarycapillarywedgepressure,biochemistry,sputumcultureandblooddrugconcentration.MainoutcomemeasuresLTrelatedindicesandpostoperativefollow-upresults.RESULTSAnastomoticstoma-relatedcomplicationswerenotfoundinallpatients,suchasstomalleakandhemorrhage.The1strecipientsurvivedfor9days,andacuterejection,severepulmonaryinfectionandarrhythmiaoccurredonthe7thday.The2ndrecipientsurvivedfor48days,andacuterejection,severepulmonaryinfection,arrhythmia,andacuterenalfailureoccurredonthe6thand21thdays.The3rdrecipientsurvivedfor56days,acuterejectionandpulmonaryinfectionoccurredonthe10thday.Followinglungtransplantation,themedicalventilationwasusedfor3-7daysfortheformer3recipients.The3recipientscoulddoindooractivity,andthe2ndand3rdrecipientscouldwalk500-700meters.The4threcipientwasventilatedfor72hourspostoperatively,andafterthathecoulddoindooractivity.Whileonthe7thday,slightrejectionoccurred,nospecialtreatmentwasgiven.Hewasdischargedonthe58thday.Nowafter1yearandahalf,hislifewasnotinfluencedbytheLT.The5threcipientreceivedacuterejectionondays4,7,and14afterLT.Following1000mgmethylprednisoloneadministration,therecipientwasawakeandcoulddoactivitiesinbed.Buthediedofseverepulmonaryinfectionandmulti-organfailurecausedbyhormoneusageonday26.The6threcipientwasextubatedonthe4thday.Fromthenon,hecouldenjoyhisindoorlifeforabout2weeks.Onthe21stday,hegothemoptysis(approximately50mL).Afterthat,aspergilluswasfoundinhissputum,andtwomorehemoptysisoccurred,theamountofwhichreached400mL.Thehemorrhagefromnon-transplantedlungwasconfirmedbyfibreopticbronchoscopy.Followingtherapywithfluconazolandamphotericinforseveraldays,therecipientdiedonthe28thdayjustbeforesalvageoperation.The7threcipientwasventilatedfor20hourspostoperatively.Following4-dayin-bedrecovery,hecoulddodailyindooractivity.Hewasdischargedonthe33thday.Onemonthlater,bronchialanastomosisstenosisoccurredandFOBtherapywasintervened.Thereafter,hegotsmoothrecovery.Now,afterapproximately5monthspostoperatively,heactsasahealthyperson.Allogenicsinglelungtransplantation-relatedindicesandLiuDR,etal,Allogeneicsinglelungtransplantationin7casesISSN1673-8225CN21-1539/RCODEN:ZLKHAH10569www.CRTER.orgpostoperativefollow-upresultsof7patientsareshowninTable2.DISCUSSIONIndicationsThebestindicationforsingleLTisidiopathicpulmonaryfibrosis[4].Itshouldbenoticedthatproperfunctioningoftheotherorgansareneccessaryintheindication[5],sometimesonlymoderatelycardiacdisorderispermitted.Inthisstudy,the5threcipientgotrightheartfailure,pericardialeffusion,pleuraleffusion,andseroperitoneumpreoperatively.Sotheperioperativepreparationfortransplantationwascomplicatedandnotsatisfied.Severalacuterejectionsattackedpostoperatively,andfinallytherecipientdiedofmulti-organfunctionfailure.LungpreservationTheshorterthewarm-ischemictimeis,thebetterthepreservationwillbe.Inthisstudy,alloperationswereperformedthroughthe4thintercostalspaceincision.Throughthisincision,ischemictimecanbemaximallyreduced,andtheoperationfieldcanbeexposedwell.Aswementionedabove,theaveragewarm-ischemictimeinthisgroupwas7.4minutes,rangingfrom2to14minutes.Keepingrespirationandstablecirculationisthebasicrulefortransplantation.Alltransplantedlungssurvivedwellinourstudyaftercold-ischemictimewhichrangedfrom150to317minutes(average259.6minutes),soitisacceptedtokeepcold-ischemictimein6hours[6].AnastomotictechniqueThoughinvestigationallovertheworld,therehasbeennodifferencefoundforthetechniqueofanostomosis[7-8].Afterseveralanimalexperiments,thepossibleproblemsoccurringduringtheLTcanbesolved.Inthepresentstudy,theaverageanastomotictimewas96.1minutes,andonecasegotmoderateanastomoticcomplications[9].CooperationMostrecipientshavemultipleorgandysfunction(pulmonarydysfunction,cardiacdysfunction,andsoon),whichmakesitacomplicateprocedureforgraft-preparation.Inthepresentstudy,wehad5recipientswithorganiccardiacdysfunction,whichcomplicatetheperioperativeperiod.Onlywiththecooperationofseveraldepartments,suchasintensivecareunit,departmentofanesthesiology,cardiacsurgery,cardiacmedicaldepartment,andrespiratorymedicaldepartment,canwesuccessfullyfinishlungtransplantation.Therapyforanti-rejectionandseverepulmonaryinfectionTillnow,noapparentprogressionofanti-rejectiontherapyhasbeenacquired.Thoughlivinglobartransplantationcanbeachieved,itcannotbecomepopular[10].Shortageofdonorandbronchiolitisistheprimaryproblemsthatwemustfaceto[7,11-12].Besides,infectionisanotherimportantproblemthatleadstothefailureofLT.Thealreadyexistedinfectionwhichresiststherapy,usageofhormone,andimmunodepressant,whichcausessecondaryinfectionorfungalinfection,aredifficulttocopewith.Forinstance,aspergillussydowiinfectioncancauseseverehemorrhage,andthehemoptysiscausedbyaspergillussydowiinfectionleadstothedeathofthe6threcipientinthepresentstudy.REFERENCES1CooperJD,PearsonFG,PattersonGA.Techniqueofsuccessfullungtransplantationinhumans.JThorscCardiovascSurg1987;93:173-1812ChenYP,ZhangZT,HanL,etal.Leftsinglelungtransplantationintreatmentofidiopathicpulmonaryfibrosis:Acasereport.ZhonghuaWaikeZazhi1996;34(1):25-273ZhaoFR,JiangYG,NaibinLiNB,etal.Experienceandlessonsoflungtransplantation.ZhonghuaWaikeZazhi1997;35(10):41-444StephenDC,MeyersBF,BattafaranoRJ,etal.Thirteen-yearexperienceinlungtransplantationforemphysema.AnnThoracSurg2002;74:1663-16705SekineY,FisherS,PerrotM,etal.Bilaterallungtransplantationusingadonorwithatrachealrightupperlobebronchus.AnnThoracSurg2002;73:308-3106SteenS,LiaoQ,WierupPN,etal.Transplantationoflungsfromnon-heart-beatingdonorsafterfunctionalassessmentexvivo.AnnThoracSurg2003;76:244-2527PattersonGA.Lungtransplantation.ChestSurgClinNorthAm2003;13:405-5778SchröderC,SchollF,DaonE,etal.Amodifiedbronchialanastomosistechniqueforlungtransplantation.AnnThoracSurg2003;75(6):16979MurthySC.Anastomoticairwaycomplicationsfollowinglungtransplantation.CurrOpinOrganTransplant2007;12:453-45810MichaelEB,PessottoR,RichardGB,etal.Long-termpulmonaryfunctionafterliving-donorlobarlungtransplantationinadults.AnnThoracSurg2005;79:418-42511FleinerFK,BuddeD,DragunM,etal.DifferencesreportingofacuterejectionsbetweenAmericanandEuropeanpublicationoflargeimmunosuppressivetrialsimpaircomparabilityofstudyresults.TransplantProc2005;37:2048-205112BothaP,ArcherL,AndersonRL,etal.Pseudomonasaeruginosacolonizationoftheallograftafterlungtransplantationandtheriskofbronchiolitisobliteranssyndrome.Transplantation2008;85(5):771-774Table2Allogenicsinglelungtransplantation-relatedindicesandpostoperativefollow-upresultsPatientWarm-Ischemictime(min)Cold-Ischemictime(min)Totalanastomotictime(min)ComplicationFollowuptim(mon)Prognosis123456752714107727815023031731226027089778595107110110AR;LI;ARRAR;LI;ARRAR;LIMAR;AR;LILI;HEAS<1<2<224<1<112DeadDeadDeadLivingDeadDeadLivingAR:acuterejection;LI:lunginfection;ARR:arrthmia;MAR:minoracuterejection;HE:hemoptysis;AS:anastomosisstenosisAverage7.4259.696.1---LiuDR,etal,Allogeneicsinglelungtransplantationin7casesP.O.Box1200,Shenyang110004cn.zglckf.com10570www.CRTER.org同种异体单肺移植7例报告☆刘德若，郭永庆，赵凤瑞，李福田，葛炳生，石彬，田燕雏，宋之乙，寿延宁，张海涛，梁朝阳，王在永，陈京宇，鲍彤，张真榕，辛育龄(中日友好医院胸外科，北京市100029)刘德若☆，男，1956年生，吉林省九台市人，汉族，1995年中国协和医科大学毕业，博士，主任医师，主要从事肺移植方面的研究。摘要：总结7例同种异体单肺移植资料的移植方案、肺保存及移植后管理监测情况。7例同种异体单肺移植患者中特发性肺纤维化3例，慢性阻塞性肺病2例，双侧矽肺、肺气肿1例，双肺结核右毁损肺1例。7例供体均为脑死亡者，供肺均采用Euro-Colins液或低钾右旋糖酐液灌注并良好保存。受体与供体血型匹配，5例患者行右侧单肺移植，2例行左侧单肺移植。肺支气管、肺动脉为端端吻合，肺静脉为心房-心房吻合。移植前后均常规应用抗生素和免疫抑制剂。肺移植后进行全面指标监测，包括心肺功能、抗生素使用及免疫抑制药物的调整。7例患者均未出现支气管、肺动静脉吻合口并发症。5例移植后2个月内死亡，1例存活近1年，另1例存活近2年。死亡者中4例死于肺感染导致多脏器功能衰竭，1例死于多曲霉菌感染致严重肺出血。6例移植后出现排斥反应，其中1例出现3次。肺移植手术适应证的选择、供肺的选择和保存、肺移植操作以及移植前后的管理已逐渐成熟，移植前心肺功能差者、移植后使用免疫抑制药物同时合并严重感染者病死率仍很高。关键词：肺移植；器官保存；并发症；器官移植中图分类号:R617文献标识码:B文章编号:1673-8225(2008)53-10567-04刘德若，郭永庆，赵凤瑞，李福田，葛炳生，石彬，田燕雏，宋之乙，寿延宁，张海涛，梁朝阳，王在永，陈京宇，鲍彤，张真榕，辛育龄.同种异体单肺移植7例报告[J].中国组织工程研究与临床康复，2008，12(53):10567-10570[http://www.crter.orghttp://cn.zglckf.com](EditedbyCaoZY/SongLP/WangL)文题(Title)：作者：单位：作者简介：基金资助项目：摘要(Abstract)：(中文500-600字，英文300-400单词)背景：目的：设计、时间及地点：对象（参与者）/材料：干预/方法：主要观察指标：结果：结论：关键词：0引言(Introduction)：1材料/对象和方法(Materials/SubjectsandMethods)设计：时间及地点：对象(参与者)/材料：方法/干预措施：主要观察指标：随访情况：设计、实施、评估者：统计学分析：2结果(Results)：合理使用图表彩图、图表的数量要精选有足够具有自明性的信息数量分析：基线资料：效果分析：统计描述；统计推断。随访情况：不良反应：可能影响结果的因素：3讨论(Discussion)：本文的重要结论：与他人他篇的异同点：存在的偏倚或不足：不成功或阴性结果的合理解释：深入研究的方向与意义，以及本文初涉现象的进一步设想和建议。4结论（Conclusion）：5参考文献(References)：≥30条6文章辅文课题背景：偏倚或不足：作者介绍：临床应用性：创新要点：重要的概念：同行评价：实验室介绍：实验设计与文章构思：在线投稿：www.crter.org(右上角)cn.zglckf.com(右上角)咨询电话：024-23384352CRTER杂志研究原著稿件体例(4.0~6.0版/篇)ISSN1673-8225CN21-1539/R2008年版权归《中国组织工程研究与临床康复》杂志社所有
